Patent details

EP3423082 Title: LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS

Basic Information

Publication number:
EP3423082
PCT Application Number:
EP2017054990
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177101607
PCT Publication Number:
WO2017149112
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS
French Title of Invention:
LIRAGLUTIDE DANS DES ÉTATS CARDIO-VASCULAIRES
German Title of Invention:
LIRAGLUTID BEI KARDIOVASKULÄREN STÖRUNGEN
SPC Number:

Dates

Filing date:
03/03/2017
Grant date:
04/08/2021
EP Publication Date:
09/01/2019
PCT Publication Date:
08/09/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2021
EP B1 Publication Date:
04/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/03/2022
Expiration date:
03/03/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/07/2021
 
 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
KVIST, Kajsa
Address:
Denmark (DK)

2

Name:
RASMUSSEN, Søren
Address:
Denmark (DK)

Priority

1

Priority Number:
16158739
Priority Date:
04/03/2016
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
16173917
Priority Date:
10/06/2016
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
16001329
Priority Date:
13/06/2016
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Number:
201715401651
Priority Date:
09/01/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/26; A61P 3/10; A61P 7/12; A61P 9/00; A61P 9/04; A61P 9/10; A61P 13/12; A61P 43/00; A61K 47/02; A61K 47/10;

Publication

European Patent Bulletin

1

Issue number:
202131
Publication date:
04/08/2021
Description:
Grant (B1)

2

Issue number:
202223
Publication date:
08/06/2022
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages